Works matching IS 17762596 AND DT 2012 AND VI 7

Results: 48

Hyperbaric oxygen therapy and cancer--a review.

Published in:

2012

By:

Moen I;
Stuhr LE;
Moen, Ingrid;
Stuhr, Linda E B

Publication type:

journal article

Erratum to: Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.

Published in:

2012

By:

Sartore-Bianchi, Andrea;
Bencardino, Katia;
Nicolantonio, Federica;
Pozzi, Federico;
Funaioli, Chiara;
Gambi, Valentina;
Arena, Sabrina;
Martini, Miriam;
Lamba, Simona;
Cassingena, Andrea;
Schiavo, Roberta;
Bardelli, Alberto;
Siena, Salvatore

Publication type:

Correction Notice

Biosimilars and market access: a question of comparability and costs?

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 227, doi. 10.1007/s11523-011-0192-7

By:

Simoens, Steven;
Verbeken, Gilbert;
Huys, Isabelle

Publication type:

Article

Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 243, doi. 10.1007/s11523-012-0221-1

By:

Saponara, Maristella;
Pantaleo, Maria;
Nannini, Margherita;
Biasco, Guido

Publication type:

Article

Peritoneal metastatic lesions of gastric cancer exhibit low expression of human epidermal growth factor receptor 2.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 213, doi. 10.1007/s11523-012-0223-z

By:

Imano, Motohiro;
Satou, Takao;
Itoh, Tatsuki;
Yasuda, Atsushi;
Kato, Hiroaki;
Shinkai, Masayuki;
Peng, Ying-Feng;
Tsubaki, Masahiro;
Yasuda, Takushi;
Imamoto, Haruhiko;
Nishida, Shozo;
Takeyama, Yoshifumi;
Okuno, Kiyokata;
Shiozaki, Hitoshi

Publication type:

Article

Hyperbaric oxygen therapy and cancer-a review.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 233, doi. 10.1007/s11523-012-0233-x

By:

Moen, Ingrid;
Stuhr, Linda

Publication type:

Article

Long lasting efficacy of sorafenib in a heavily pretreated patient with thymic carcinoma.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 247, doi. 10.1007/s11523-012-0235-8

By:

Neuhaus, Thomas;
Luyken, Joachim

Publication type:

Article

Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 253, doi. 10.1007/s11523-012-0237-6

By:

Le Tourneau, Christophe;
Kamal, Maud;
Trédan, Olivier;
Delord, Jean-Pierre;
Campone, Mario;
Goncalves, Anthony;
Isambert, Nicolas;
Conroy, Thierry;
Gentien, David;
Vincent-Salomon, Anne;
Pouliquen, Anne-Lise;
Servant, Nicolas;
Stern, Marc-Henri;
Le Corroller, Anne-Gaëlle;
Armanet, Sébastien;
Rio Frio, Thomas;
Paoletti, Xavier

Publication type:

Article

Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation.

Published in:

Targeted Oncology, 2012, v. 7, n. 4, p. 217, doi. 10.1007/s11523-012-0236-7

By:

Dai, Furong;
Zhang, Yi;
Zhu, Xin;
Shan, Nianchun;
Chen, Yuxiang

Publication type:

Article

Oncology in 2012: from personalized medicine to precision medicine.

Published in:

2012

By:

Morere, J.

Publication type:

Editorial

Inhibition of mTOR in carcinoid tumors.

Published in:

Targeted Oncology, 2012, v. 7, n. 3, p. 189, doi. 10.1007/s11523-012-0225-x

By:

Grozinsky-Glasberg, Simona;
Pavel, Marianne

Publication type:

Article

Profiling mTOR pathway in neuroendocrine tumors.

Published in:

Targeted Oncology, 2012, v. 7, n. 3, p. 183, doi. 10.1007/s11523-012-0226-9

By:

Cingarlini, S.;
Bonomi, M.;
Corbo, V.;
Scarpa, A.;
Tortora, G.

Publication type:

Article

Streptozocin-based chemotherapy is not history in neuroendocrine tumours.

Published in:

Targeted Oncology, 2012, v. 7, n. 3, p. 161, doi. 10.1007/s11523-012-0224-y

By:

Weatherstone, Katie;
Meyer, Tim

Publication type:

Article

New treatment options with cytotoxic agents in neuroendocrine tumours.

Published in:

Targeted Oncology, 2012, v. 7, n. 3, p. 169, doi. 10.1007/s11523-012-0228-7

By:

Hammel, Pascal;
Hentic, Olivia;
Neuzillet, Cindy;
Faivre, Sandrine;
Raymond, Eric;
Ruszniewski, Philippe

Publication type:

Article

Targeting neuroendocrine tumor: mixing standard options with novel therapies.

Published in:

2012

By:

Raymond, Eric;
Dreyer, Chantal;
Faivre, Sandrine

Publication type:

Editorial

Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors.

Published in:

Targeted Oncology, 2012, v. 7, n. 3, p. 153, doi. 10.1007/s11523-012-0230-0

By:

Gaujoux, Sébastien;
Sauvanet, Alain;
Belghiti, Jacques

Publication type:

Article

Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies.

Published in:

Targeted Oncology, 2012, v. 7, n. 3, p. 173, doi. 10.1007/s11523-012-0229-6

By:

Tijeras-Raballand, Annemilaï;
Neuzillet, Cindy;
Couvelard, Anne;
Serova, Maria;
Gramont, Armand;
Hammel, Pascal;
Raymond, Eric;
Faivre, Sandrine

Publication type:

Article

Erratum to: Inhibition of mTOR in carcinoid tumors.

Published in:

2012

By:

Grozinsky-Glasberg, Simona;
Pavel, Marianne

Publication type:

Correction Notice

Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.

Published in:

Targeted Oncology, 2012, v. 7, n. 3, p. 199, doi. 10.1007/s11523-012-0227-8

By:

Madrid, Andres;
Campbell, Nicholas;
Smith, Sonali;
Cohn, Susan;
Salgia, Ravi

Publication type:

Article

Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.

Published in:

2012

By:

Kim BY;
Jonasch E;
McCutcheon IE;
Kim, Betty Y S;
Jonasch, Eric;
McCutcheon, Ian E

Publication type:

journal article

Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease.

Published in:

Targeted Oncology, 2012, v. 7, n. 2, p. 145, doi. 10.1007/s11523-012-0214-0

By:

Kim, Betty;
Jonasch, Eric;
McCutcheon, Ian

Publication type:

Article

Imaging response in neuroendocrine tumors treated with targeted therapies: the experience of sunitinib.

Published in:

Targeted Oncology, 2012, v. 7, n. 2, p. 127, doi. 10.1007/s11523-012-0216-y

By:

Faivre, Sandrine;
Ronot, Maxime;
Dreyer, Chantal;
Serrate, Camille;
Hentic, Olivia;
Bouattour, Mohamed;
Bruno, Onorina;
Couvelard, Anne;
Vilgrain, Valérie;
Raymond, Eric

Publication type:

Article

Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer.

Published in:

Targeted Oncology, 2012, v. 7, n. 2, p. 135, doi. 10.1007/s11523-012-0215-z

By:

Liu, Shu-Li;
Han, Yang;
Zhang, Yong;
Xie, Cheng-Yao;
Wang, En-Hua;
Miao, Yuan;
Li, Hai-Ying;
Xu, Hong-Tao;
Dai, Shun-Dong

Publication type:

Article

New targeted agents in gastroenteropancreatic neuroendocrine tumors.

Published in:

Targeted Oncology, 2012, v. 7, n. 2, p. 99, doi. 10.1007/s11523-012-0218-9

By:

Benavent, Marta;
Miguel, Maria;
Garcia-Carbonero, Rocio

Publication type:

Article

Relevance of angiogenesis in neuroendocrine tumors.

Published in:

Targeted Oncology, 2012, v. 7, n. 2, p. 93, doi. 10.1007/s11523-012-0217-x

By:

Teulé, Alexandre;
Casanovas, Oriol

Publication type:

Article

Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.

Published in:

Targeted Oncology, 2012, v. 7, n. 2, p. 107, doi. 10.1007/s11523-012-0219-8

By:

Zappa, Magaly;
Abdel-Rehim, Mohamed;
Hentic, Olivia;
Vullierme, Marie-Pierre;
Ruszniewski, Philippe;
Vilgrain, Valérie

Publication type:

Article

Sunitinib in pancreatic neuroendocrine tumors.

Published in:

Targeted Oncology, 2012, v. 7, n. 2, p. 117, doi. 10.1007/s11523-012-0220-2

By:

Raymond, Eric;
Hammel, Pascal;
Dreyer, Chantal;
Maatescu, Christian;
Hentic, Olivia;
Ruszniewski, Philippe;
Faivre, Sandrine

Publication type:

Article

New treatments of pancreatic neuroendocrine tumors: why using them? How to use them?

Published in:

2012

By:

Raymond, Eric;
Ruszniewski, Philippe

Publication type:

Editorial

Risk management of biosimilars in oncology: each medicine is a work in progress.

Published in:

2012

By:

Vulto, Arnold G;
Crow, Stacy A

Publication type:

journal article

Presently available biosimilars in hematology-oncology: G-CSF.

Published in:

2012

By:

Gascon, Pere

Publication type:

journal article

Biosimilars: Is absence of proof of difference, proof of absence of difference?

Published in:

2012

By:

Dicato, M

Publication type:

Journal Article

The economic pressures for biosimilar drug use in cancer medicine.

Published in:

Targeted Oncology, 2012, v. 7, p. 57, doi. 10.1007/s11523-011-0196-3

By:

Cornes, Paul

Publication type:

Article

Biosimilars: Is absence of proof of difference, proof of absence of difference?

Published in:

2012

By:

Dicato, M.

Publication type:

Editorial

Colony stimulating factors (CSF) biosimilars. Progress?

Published in:

Targeted Oncology, 2012, v. 7, p. 17, doi. 10.1007/s11523-011-0189-2

By:

Scotté, Florian;
Launay-Vacher, Vincent;
Rey, Jean-Baptiste

Publication type:

Article

Erythropoietin biosimilars currently available in hematology-oncology.

Published in:

Targeted Oncology, 2012, v. 7, p. 25, doi. 10.1007/s11523-011-0191-8

By:

Kamioner, Didier

Publication type:

Article

Presently available biosimilars in hematology-oncology: G-CSF.

Published in:

Targeted Oncology, 2012, v. 7, p. 29, doi. 10.1007/s11523-011-0190-9

By:

Gascon, Pere

Publication type:

Article

What do prescribers think of biosimilars?

Published in:

Targeted Oncology, 2012, v. 7, p. 51, doi. 10.1007/s11523-011-0193-6

By:

Aapro, M.

Publication type:

Article

Low molecular weight heparin biosimilars: how much similarity for how much clinical benefit?

Published in:

Targeted Oncology, 2012, v. 7, p. 35, doi. 10.1007/s11523-011-0194-5

By:

Drouet, Ludovic

Publication type:

Article

Risk management of biosimilars in oncology: each medicine is a work in progress.

Published in:

Targeted Oncology, 2012, v. 7, p. 43, doi. 10.1007/s11523-011-0188-3

By:

Vulto, Arnold;
Crow, Stacy

Publication type:

Article

Biosimilar rhG-CSFs: how similar are they?

Published in:

Targeted Oncology, 2012, v. 7, p. 3, doi. 10.1007/s11523-011-0187-4

By:

Gravel, Patricia;
Naik, Aarti;
Cotonnec, Jean-Yves

Publication type:

Article

Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival.

Published in:

2012

By:

Morre M;
Beq S;
Morre, Michel;
Beq, Stéphanie

Publication type:

journal article

Targeting regulatory T cells.

Published in:

Targeted Oncology, 2012, v. 7, n. 1, p. 15, doi. 10.1007/s11523-012-0208-y

By:

Ménétrier-Caux, Christine;
Curiel, Tyler;
Faget, Julien;
Manuel, Manuarii;
Caux, Christophe;
Zou, Weiping

Publication type:

Article

Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?

Published in:

Targeted Oncology, 2012, v. 7, n. 1, p. 3, doi. 10.1007/s11523-012-0207-z

By:

Jotereau, F.;
Gervois, N.;
Labarrière, N.

Publication type:

Article

Recent successes of cancer immunotherapy: a new dimension in personalized medicine?

Published in:

2012

By:

Caux, Christophe;
Zitvogel, Laurence

Publication type:

Editorial

A review on various targeted anticancer therapies.

Published in:

Targeted Oncology, 2012, v. 7, n. 1, p. 69, doi. 10.1007/s11523-012-0212-2

By:

Li, Junjie;
Chen, Feng;
Cona, Marlein;
Feng, Yuanbo;
Himmelreich, Uwe;
Oyen, Raymond;
Verbruggen, Alfons;
Ni, Yicheng

Publication type:

Article

Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival.

Published in:

Targeted Oncology, 2012, v. 7, n. 1, p. 55, doi. 10.1007/s11523-012-0210-4

By:

Morre, Michel;
Beq, Stéphanie

Publication type:

Article

Advancement in the research on vascular endothelial growth inhibitor (VEGI).

Published in:

Targeted Oncology, 2012, v. 7, n. 1, p. 87, doi. 10.1007/s11523-012-0206-0

By:

Duan, Lijiao;
Yang, Ganggang;
Zhang, Ruigang;
Feng, Lijuan;
Xu, Cunshuan

Publication type:

Article

Targeting pattern recognition receptors in cancer immunotherapy.

Published in:

Targeted Oncology, 2012, v. 7, n. 1, p. 29, doi. 10.1007/s11523-012-0213-1

By:

Goutagny, Nadège;
Estornes, Yann;
Hasan, Uzma;
Lebecque, Serge;
Caux, Christophe

Publication type:

Article